The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VXRT, GLNG and BMRN
*NEW YORK, NY / ACCESSWIRE / September 30, 2020 /* The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. *If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.*
*Vaxart, Inc. (NASDAQ:VXRT)*
Class Period: June 25, 2020 - July 25, 2020
Lead Plaintiff Deadline: October 23, 2020
The VXRT lawsuit alleges Vaxart, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.
*Learn about your recoverable losses in VXRT*: http://www.kleinstocklaw.com/pslra-1/vaxart-inc-loss-submission-form?id=9697&from=1
*Golar LNG Limited (NASDAQ:GLNG)*
Class Period: April 30, 2020 - September 24, 2020
Lead Plaintiff Deadline: November 23, 2020
Golar LNG Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) certain employees, including the Chief Executive Officer of Hygo Energy Transition Ltd. f/k/a Golar Power Limited ("Hygo"), had bribed third parties, thereby violating anti-bribery policies; (2) as a result, the Company was likely to face regulatory scrutiny and possible penalties; (3) as a result of the foregoing reputational harm, Hygo's valuation ahead of its initial public offering would be significantly impaired; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
*Learn about your recoverable losses in GLNG*: http://www.kleinstocklaw.com/pslra-1/golar-lng-limited-loss-submission-form?id=9697&from=1
*BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)*
Class Period: February 28, 2020 - August 18, 2020
Lead Plaintiff Deadline: November 24, 2020
The BMRN lawsuit alleges that throughout the class period, BioMarin Pharmaceutical Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) differences between the Phase 1/2 and Phase 3 study of valoctocogene roxaparvovec, an investigational adenoassociated virus gene therapy, limited the reliability of the Phase 1/2 study to support valoctocogene roxaparvovec's durability of effect; (ii) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the Biologics License Application for valoctocogene roxaparvovec without additional data; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
*Learn about your recoverable losses in BMRN*: http://www.kleinstocklaw.com/pslra-1/biomarin-pharmaceutical-inc-loss-submission-form?id=9697&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
*CONTACT:*
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
*SOURCE:* The Klein Law Firm
View source version on accesswire.com:
https://www.accesswire.com/608561/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-VXRT-GLNG-and-BMRN